Skip to content

FDA approves landmark pancreatic cancer drug that’s shown to improve survival · Hindustan Sphere

Hindustan SphereAll India

Search Get alerts

Home›Health›2 sources

Health · 2 sources covering this

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

2 L · 0 C · 0 R

How 2 sources are covering this

The HinduLean L·1h ago
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer
Read at The Hindu →
The HinduLean L·

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/32ca2e24ff075231050dac83fccb0f9f0e762555"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="FDA approves landmark pancreatic cancer drug that’s shown to improve survival"></iframe>

More from Health

MintLean R·1h ago

Nepal Floods Live Updates: 332 bodies found, death toll hits 270, 650 foreigners missing

MintLean R·

Daily briefing

Hindustan Sphere in your inbox

The 5 stories from all india you actually need to read. Once a day, no fluff. Unsubscribe in one click.

Hindustan Sphere

About
Methodology
Sources
Careers
Contact
Editorial standards

Sections

Politics
Business
Markets

2h ago

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer

Read at The Hindu →

1h ago

Will safety risks for kids persist on Facebook, Instagram in India? Here's what we know about Meta’s teen protections

MintLean R·2h ago

'Reserves right to act': China warns of countermeasures as US weighs 7.5% tariff over 'overcapacity'

MintLean R·2h ago

Row over CJI, BCI chief invites: National Law School cancels 2026 convocation, degrees to be awarded in absentia

Reader

Today's briefing
Archive
Topics
Editorial guides
Notifications
Embed widgets
Bookmarks
Search

Trust & legal

Coverage stats
Corrections
Privacy
Terms
Security

Across the network

Hyderabad Adda
Hyderabad's hyperlocal portal
Telangana Buzz
State-wide news + culture
Stateside Daily
American daily, distilled

© 2026 Hindustan Sphere. All headlines are sourced from third-party publishers; we never republish article bodies.

All India